C9ORF129 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.471800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.179000E-01
Normal-vs-Stage2
6.065800E-01
Normal-vs-Stage3
1.867980E-01
Normal-vs-Stage4
3.368400E-01
Stage1-vs-Stage2
8.315600E-01
Stage1-vs-Stage3
1.468390E-02
Stage1-vs-Stage4
3.876200E-01
Stage2-vs-Stage3
6.111600E-02
Stage2-vs-Stage4
3.596800E-01
Stage3-vs-Stage4
1.865180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.803200E-01
Normal-vs-AfricanAmerican
3.831600E-01
Normal-vs-Asian
6.776200E-01
Caucasian-vs-AfricanAmerican
2.784600E-01
Caucasian-vs-Asian
7.429200E-01
AfricanAmerican-vs-Asian
5.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.885400E-01
Normal-vs-Female
7.230400E-01
Male-vs-Female
6.447000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.918600E-01
Normal-vs-Age(41-60Yrs)
4.966600E-01
Normal-vs-Age(61-80Yrs)
7.047000E-01
Normal-vs-Age(81-100Yrs)
9.673200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.719200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.890200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.470800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.353800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.728050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.217200E-01
Normal-vs-Daily Drinker
9.617200E-01
Normal-vs-Weekly Drinker
8.684800E-01
Normal-vs-Occasional Drinker
5.440200E-01
Normal-vs-Social Drinker
4.022200E-01
Non Drinker-vs-Daily Drinker
3.988000E-01
Non Drinker-vs-Weekly Drinker
7.271800E-01
Non Drinker-vs-Occasional Drinker
3.777600E-01
Non Drinker-vs-Social Drinker
4.284200E-01
Daily Drinker-vs-Weekly Drinker
7.068200E-01
Daily Drinker-vs-Occasional Drinker
1.471560E-01
Daily Drinker-vs-Social Drinker
1.434250E-01
Weekly Drinker-vs-Occasional Drinker
3.211800E-01
Weekly Drinker-vs-Social Drinker
3.031600E-01
Occasional Drinker-vs-Social Drinker
7.572000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.068610E-01
Normal-vs-Grade 2
8.170200E-02
Normal-vs-Grade 3
1.432310E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.347250E-01
Grade 1-vs-Grade 3
7.005700E-02
Grade 1-vs-Grade 4
1.068610E-01
Grade 2-vs-Grade 3
9.185600E-01
Grade 2-vs-Grade 4
8.170200E-02
Grade 3-vs-Grade 4
1.432310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.428800E-01
Normal-vs-NonDiabetic
6.835400E-01
Diabetic-vs-NonDiabetic
9.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.650600E-01
Normal-vs-NoPancreatitis
6.741800E-01
Pancreatitis-vs-NoPancreatitis
7.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.934400E-01
Normal-vs-N1
6.232400E-01
N0-vs-N1
8.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.201400E-01
Normal-vs-TP53-NonMutant
4.925800E-01
TP53-Mutant-vs-TP53-NonMutant
3.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
